Cargando…

Ilicicolin A Exerts Antitumor Effect in Castration-Resistant Prostate Cancer Via Suppressing EZH2 Signaling Pathway

The Polycomb protein enhancer of zeste homolog 2 (EZH2) has critical roles in prostate cancer (PCa) progression and drug-resistance, which remains an obstacle for PCa treatment. Enzalutamide (ENZ) is a second-generation androgen receptor antagonist employed for treatment of metastatic castration-res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Lang, Luo, Xiaowei, Yang, Ping, Zhang, Yanting, Huang, Jialuo, Wang, Hong, Guo, Yinfeng, Huang, Weifeng, Chen, Zhiqiang, Wang, Shusheng, Wang, Junjian, Lei, Jinping, Xiang, Songtao, Liu, Yonghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578973/ https://www.ncbi.nlm.nih.gov/pubmed/34776951 http://dx.doi.org/10.3389/fphar.2021.723729

Ejemplares similares

Heterologous Expression of Ilicicolin H Biosynthetic Gene Cluster and Production of a New Potent Antifungal Reagent, Ilicicolin J
por: Lin, Xiaojing, et al.
Publicado: (2019)

Trichoderma reesei Contains a Biosynthetic Gene Cluster That Encodes the Antifungal Agent Ilicicolin H
por: Shenouda, Mary L., et al.
Publicado: (2021)

Combining OSMAC, metabolomic and genomic methods for the production and annotation of halogenated azaphilones and ilicicolins in termite symbiotic fungi
por: Hebra, Téo, et al.
Publicado: (2022)

Orphan nuclear receptors as regulators of intratumoral androgen biosynthesis in castration-resistant prostate cancer
por: Zhou, Jianfu, et al.
Publicado: (2021)

Targeting castration-resistant prostate cancer with a novel RORγ antagonist elaiophylin
por: Zheng, Jianwei, et al.
Publicado: (2020)

Easy or Not—The Advances of EZH2 in Regulating T Cell Development, Differentiation, and Activation in Antitumor Immunity
por: Huang, Jiaqi, et al.
Publicado: (2021)

LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer
por: Wang, Dejie, et al.
Publicado: (2015)

Polycomb-independent activity of EZH2 in castration resistant prostate cancer
por: Xu, Kexin, et al.
Publicado: (2013)

Combining EZH2 and HDAC inhibitors to target castration-resistant prostate cancers
por: Coulter, Jonathan B., et al.
Publicado: (2023)

Targeting autophagy peptidase ATG4B with a novel natural product inhibitor Azalomycin F4a for advanced gastric cancer
por: Zhong, Lin, et al.
Publicado: (2022)

Gimatecan exerts potent antitumor activity against gastric cancer in vitro and in vivo via AKT and MAPK signaling pathways
por: Chen, Zuhua, et al.
Publicado: (2017)

Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma
por: Piunti, Andrea, et al.
Publicado: (2022)

CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating β-catenin/STAT3 signaling
por: Huang, Renlun, et al.
Publicado: (2020)

Juglone exerts antitumor effect in ovarian cancer cells
por: Fang, Fang, et al.
Publicado: (2015)

Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor
por: Honma, Daisuke, et al.
Publicado: (2017)

Combating castration-resistant prostate cancer by co-targeting the epigenetic regulators EZH2 and HDAC
por: Schade, Amy E., et al.
Publicado: (2023)

The impact of castration on physiological responses to exertional heat stroke in mice
por: Garcia, Christian K., et al.
Publicado: (2022)

Coriloxin Exerts Antitumor Effects in Human Lung Adenocarcinoma Cells
por: Kuo, Yu-Hsuan, et al.
Publicado: (2022)

ICAM1 antibody drug conjugates exert potent antitumor activity in papillary and anaplastic thyroid carcinoma
por: Zhang, Peng, et al.
Publicado: (2023)

PCC0208018 exerts antitumor effects by activating effector T cells
por: Ge, Minmin, et al.
Publicado: (2019)

Inhibition of EZH2 by chemo- and radiotherapy agents and small molecule inhibitors induces cell death in castration-resistant prostate cancer
por: Wu, Changping, et al.
Publicado: (2015)

IL-9 Exerts Antitumor Effects in Colon Cancer and Transforms the Tumor Microenvironment In Vivo
por: Wang, Jin, et al.
Publicado: (2019)

Activated platelet membrane nanovesicles recruit neutrophils to exert the antitumor efficiency
por: Shang, Yinghui, et al.
Publicado: (2022)

A Screened GPR1 Peptide Exerts Antitumor Effects on Triple-Negative Breast Cancer
por: Huang, Chen, et al.
Publicado: (2020)

EZH2: An Accomplice of Gastric Cancer
por: Yu, Wuhan, et al.
Publicado: (2023)

Inhibition of EZH2 exerts antitumorigenic effects in renal cell carcinoma via LATS1
por: Hong, Seong Hwi, et al.
Publicado: (2023)

Aloperine Exerts Antitumor Effects on Bladder Cancer in vitro
por: Zhang, Lijun, et al.
Publicado: (2020)

Inhibition of lipid metabolism exerts antitumor effects on rhabdomyosarcoma
por: Miyagaki, Satoshi, et al.
Publicado: (2021)

CASTRATION EXERTS NO INFLUENCE UPON THE GROWTH OF TRANSPLANTED OR SPONTANEOUS TUMORS IN MICE AND RATS
por: Hilario, Jose S.
Publicado: (1915)

Synthesis and Antitumor Activities of Phenanthrene-Based Alkaloids
por: Li, Songtao, et al.
Publicado: (2009)

Chromogranin A is a predictor of prognosis in patients with prostate cancer: a systematic review and meta-analysis
por: Guo, Zhenlang, et al.
Publicado: (2019)

Increased AR expression in castration-resistant prostate cancer rapidly induces AR signaling reprogramming with the collaboration of EZH2
por: Labaf, Maryam, et al.
Publicado: (2022)

Modulation of EZH2 Activity Induces an Antitumoral Effect and Cell Redifferentiation in Anaplastic Thyroid Cancer
por: de Mello, Diego Claro, et al.
Publicado: (2023)

Ezh2 phosphorylation state determines its capacity to maintain CD8(+) T memory precursors for antitumor immunity
por: He, Shan, et al.
Publicado: (2017)

Impact of Time to Castration Resistance on Cytoreductive Radiotherapy in Metastatic Castration-Resistant Prostate Cancer
por: Mai, Lixin, et al.
Publicado: (2020)

Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein
por: Tripathi, Brajendra K., et al.
Publicado: (2021)

Combination of Expanded Allogeneic NK Cells and T Cell-Based Immunotherapy Exert Enhanced Antitumor Effects
por: Wang, Xiao, et al.
Publicado: (2022)

Tumor-suppressive function of EZH2 is through inhibiting glutaminase
por: Liu, Yongfeng, et al.
Publicado: (2021)

EZH2 takes the stage when BRCA1 loses
por: Wang, Lan, et al.
Publicado: (2013)

Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemia
por: Jiang, Xuejie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m1nksc9eprns3cm85eq491quv0